Norman Baylor, Phd
Chief Operations Officer
immunology
Immune Biosolutions
Antarctica
Biography
Norman Baylor joined the IDRI Board of Directors in December 2016. Baylor currently serves as President and CEO of Biologics Consulting, a regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices based in Alexandria, VA. He joined Biologics Consulting after 20 years with the FDA, most recently as the director of the Office of Vaccines Research and Review. During his tenure at the FDA, Baylor evaluated and facilitated the development and licensure of numerous new vaccines, such as acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV) influenza, zoster and all of the new-generation combination vaccines.
Research Interest
Norman Baylor joined the IDRI Board of Directors in December 2016. Baylor currently serves as President and CEO of Biologics Consulting, a regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices based in Alexandria, VA. He joined Biologics Consulting after 20 years with the FDA, most recently as the director of the Office of Vaccines Research and Review. During his tenure at the FDA, Baylor evaluated and facilitated the development and licensure of numerous new vaccines, such as acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV) influenza, zoster and all of the new-generation combination vaccines.
